Royal Bank of Canada’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.3M Buy
1,747,151
+565,187
+48% +$9.47M 0.01% 1150
2025
Q1
$18.2M Buy
1,181,964
+4,361
+0.4% +$67K ﹤0.01% 1231
2024
Q4
$26M Buy
1,177,603
+173,050
+17% +$3.81M 0.01% 1062
2024
Q3
$18.1M Buy
1,004,553
+489,755
+95% +$8.83M ﹤0.01% 1233
2024
Q2
$8.37M Buy
514,798
+118,716
+30% +$1.93M ﹤0.01% 1620
2024
Q1
$5.59M Buy
396,082
+73,991
+23% +$1.04M ﹤0.01% 1852
2023
Q4
$3.36M Sell
322,091
-2,300
-0.7% -$24K ﹤0.01% 2230
2023
Q3
$3.31M Sell
324,391
-5,280
-2% -$53.8K ﹤0.01% 2100
2023
Q2
$2.48M Buy
329,671
+62,522
+23% +$471K ﹤0.01% 2344
2023
Q1
$2.37M Buy
267,149
+10,137
+4% +$89.8K ﹤0.01% 2387
2022
Q4
$2.34M Sell
257,012
-202,725
-44% -$1.85M ﹤0.01% 2421
2022
Q3
$3.71M Buy
459,737
+63,560
+16% +$513K ﹤0.01% 2001
2022
Q2
$2.98M Sell
396,177
-548,244
-58% -$4.12M ﹤0.01% 2210
2022
Q1
$8.87M Sell
944,421
-158,744
-14% -$1.49M ﹤0.01% 1572
2021
Q4
$8.84M Buy
1,103,165
+123,491
+13% +$989K ﹤0.01% 1686
2021
Q3
$9.54M Buy
979,674
+243,822
+33% +$2.37M ﹤0.01% 1621
2021
Q2
$7.29M Buy
735,852
+12,982
+2% +$129K ﹤0.01% 1809
2021
Q1
$8.34M Sell
722,870
-211,996
-23% -$2.45M ﹤0.01% 1666
2020
Q4
$9.02M Buy
934,866
+482,596
+107% +$4.66M ﹤0.01% 1555
2020
Q3
$4.08M Sell
452,270
-40,247
-8% -$363K ﹤0.01% 1862
2020
Q2
$6.07M Buy
492,517
+20,423
+4% +$252K ﹤0.01% 1588
2020
Q1
$4.24M Sell
472,094
-4,601
-1% -$41.3K ﹤0.01% 1679
2019
Q4
$4.67M Sell
476,695
-572,322
-55% -$5.61M ﹤0.01% 1848
2019
Q3
$7.22M Buy
1,049,017
+421,092
+67% +$2.9M ﹤0.01% 1529
2019
Q2
$5.79M Sell
627,925
-334,488
-35% -$3.09M ﹤0.01% 1664
2019
Q1
$15.1M Sell
962,413
-162,203
-14% -$2.54M 0.01% 1071
2018
Q4
$17.3M Buy
1,124,616
+170,778
+18% +$2.63M 0.01% 905
2018
Q3
$20.5M Buy
953,838
+12,710
+1% +$274K 0.01% 940
2018
Q2
$22.9M Sell
941,128
-104,393
-10% -$2.54M 0.01% 854
2018
Q1
$17.9M Sell
1,045,521
-223,790
-18% -$3.83M 0.01% 993
2017
Q4
$24.1M Sell
1,269,311
-594,400
-32% -$11.3M 0.01% 840
2017
Q3
$32.8M Sell
1,863,711
-818,174
-31% -$14.4M 0.02% 653
2017
Q2
$89.1M Sell
2,681,885
-136,052
-5% -$4.52M 0.05% 285
2017
Q1
$90.4M Sell
2,817,937
-36,405
-1% -$1.17M 0.05% 272
2016
Q4
$103M Buy
2,854,342
+604,236
+27% +$21.9M 0.06% 252
2016
Q3
$104M Sell
2,250,106
-17,878
-0.8% -$823K 0.06% 242
2016
Q2
$114M Buy
2,267,984
+154,377
+7% +$7.75M 0.07% 210
2016
Q1
$113M Buy
2,113,607
+317,822
+18% +$17M 0.07% 195
2015
Q4
$118M Sell
1,795,785
-8,664
-0.5% -$569K 0.08% 177
2015
Q3
$102M Buy
1,804,449
+1,515
+0.1% +$85.5K 0.08% 166
2015
Q2
$107M Buy
1,802,934
+236,231
+15% +$14M 0.07% 177
2015
Q1
$97.6M Buy
1,566,703
+244,586
+18% +$15.2M 0.07% 188
2014
Q4
$76M Buy
1,322,117
+53,423
+4% +$3.07M 0.05% 256
2014
Q3
$68.2M Buy
1,268,694
+3,061
+0.2% +$165K 0.05% 245
2014
Q2
$66.3M Sell
1,265,633
-263,263
-17% -$13.8M 0.04% 259
2014
Q1
$80.8M Sell
1,528,896
-199,798
-12% -$10.6M 0.06% 214
2013
Q4
$69.3M Sell
1,728,694
-939,331
-35% -$37.6M 0.05% 248
2013
Q3
$101M Sell
2,668,025
-659,493
-20% -$24.9M 0.08% 163
2013
Q2
$130M Buy
+3,327,518
New +$130M 0.11% 111